Biomedical Waste Disposal Inc is categorized under Refuse Systems in Studio City, CA and active since 2011.
Biomedical Waste Disposal Inc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Refuse Systems business, which does work in the B2B market, and is classified as a Refuse Systems, under code number 562219 by the NAICS.
If you are seeking more information, feel free to contact Alik Ghazaryan at the company’s single location by writing to 12930 Ventura Boulevard, Studio City, California CA 91604 or by phoning (877) 644-2424. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Biomedical Waste Disposal Inc |
Contact Person: | Alik Ghazaryan |
Address: | 12930 Ventura Boulevard, Studio City, California 91604 |
Phone Number: | (877) 644-2424 |
Website Address: | biomedwastedisposal.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Refuse Systems |
SIC Code: | 4953 |
NAICS Code: | 562219 |
Share This Business: |
Biomedical Waste Disposal Inc was started in 2011 to provide professional Refuse Systems under the SIC code 4953 and NAICS code 562219. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Alik Ghazaryan for inquiries that concern Biomedical Waste Disposal Inc by calling the company number (877) 644-2424, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomedical Waste Disposal Inc can be found at the coordinates 34.14517,-118.414824 as well as the street address 12930 Ventura Boulevard in Studio City, California 91604.
For its online presence, you may visit Biomedical Waste Disposal Inc’s website at biomedwastedisposal.com and engage with its social media outlets through on Twitter and on Facebook.